Acadia Healthcare (NASDAQ: ACHC) saw its stock soar 5.13% in pre-market trading on Tuesday, following the release of better-than-expected first-quarter financial results and positive analyst ratings. The behavioral healthcare services provider continues to demonstrate strong performance, attracting investor interest.
After the closing bell on Monday, Acadia Healthcare reported adjusted earnings of 40 cents per share for Q1, surpassing market estimates of 36 cents per share. The company's quarterly sales came in at $770.50 million, slightly above expectations of $769.84 million. This strong financial performance likely fueled the stock's upward movement.
Adding to the positive sentiment, multiple analysts have reaffirmed their bullish stance on Acadia Healthcare. Bank of America Securities analyst Joanna Gajuk reiterated a Buy rating on the stock, while TD Cowen analyst Ryan Langston maintained a Buy rating with a price target of $44.00. These endorsements from Wall Street analysts further support investor confidence in Acadia Healthcare's growth prospects and financial health, contributing to the stock's significant rise.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。